We focus on extracting more information and understanding from bioreactor experiments to enable development of processes that consistently produce high-quality biotherapeutic products:
A new state-of-the-art laboratory has also been commissioned that can be used to develop, optimize, and scale up biotherapeutic manufacturing processes. In addition to the novel MAST platform, this lab offers an expanded range of capabilities:
The sampling challenges associated with maintaining sterility and processing high-density cell solutions have been resolved by development of the MAST platform. Enabling at-line analysis, MAST facilitates collection of real-time samples that can be obtained from multiple reactors and sent to a wide variety of devices for optimized process control, including analyzers, cell removal systems, sample-retain devices, and sample processes. MAST units have been installed at multiple client facilities and have taken thousands of samples in cell-culture, microbial, and downstream applications without loss of sample integrity or bioreactor sterility. Capsugel continues to expand the instrumentation that can be integrated with MAST.